Cargando…

Treatment of COVID-19 by stage: any space left for mesenchymal stem cell therapy?

In many countries, COVID-19 now accounts for more deaths per year than car accidents and even the deadliest wars. Combating the viral pandemics requires a coordinated effort to develop therapeutic protocols adaptable to the disease severity. In this review article, we summarize a graded approach aim...

Descripción completa

Detalles Bibliográficos
Autores principales:	Spinetti, Gaia, Avolio, Elisa, Madeddu, Paolo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8127835/ https://www.ncbi.nlm.nih.gov/pubmed/33988482 http://dx.doi.org/10.2217/rme-2020-0189

Ejemplares similares

Personalized Cardiovascular Regenerative Medicine: Targeting the Extreme Stages of Life
por: Madeddu, Paolo, et al.
Publicado: (2019)

Oxidative Stress in Mesenchymal Stem Cell Senescence: Regulation by Coding and Noncoding RNAs
por: Vono, Rosa, et al.
Publicado: (2018)

Stem cell therapy and tissue engineering for correction of congenital heart disease
por: Avolio, Elisa, et al.
Publicado: (2015)

Commentary: Mending a broken heart: The ongoing quest for mesenchymal stem cell therapy for ischemic cardiomyopathy
por: Spinetti, Gaia, et al.
Publicado: (2021)

Umbilical Cord Pericytes Provide a Viable Alternative to Mesenchymal Stem Cells for Neonatal Vascular Engineering
por: Cathery, William, et al.
Publicado: (2021)

Migration towards SDF-1 selects angiogenin-expressing bone marrow monocytes endowed with cardiac reparative activity in patients with previous myocardial infarction
por: Ascione, Raimondo, et al.
Publicado: (2015)

Multi-Omics Analysis of Diabetic Heart Disease in the db/db Model Reveals Potential Targets for Treatment by a Longevity-Associated Gene
por: Faulkner, Ashton, et al.
Publicado: (2020)

Space-time superalgebras in any dimensions
por: Ferrara, Sergio
Publicado: (2001)

Cell Therapy for Critical Limb Ischemia: Advantages, Limitations, and New Perspectives for Treatment of Patients with Critical Diabetic Vasculopathy
por: Gu, Y., et al.
Publicado: (2021)

Is there any reproductive future left for men?
por: Tournaye, H.
Publicado: (2012)

Nerve growth factor gene therapy improves bone marrow sensory innervation and nociceptor-mediated stem cell release in a mouse model of type 1 diabetes with limb ischaemia
por: Dang, Zexu, et al.
Publicado: (2019)

Laminational models for some spaces of polynomials of any degree
por: Blokh, Alexander, et al.
Publicado: (2020)

FoxA2 hunting research identifies the early trail of mesenchymal differentiation
por: Madeddu, Paolo
Publicado: (2013)

Are there any association between COVID-19 severity and immunosuppressive therapy?
por: Hormati, Ahmad, et al.
Publicado: (2020)

Mechanical Strain Induces Transcriptomic Reprogramming of Saphenous Vein Progenitors
por: Maselli, Davide, et al.
Publicado: (2022)

Circulating MicroRNA-15a Associates With Retinal Damage in Patients With Early Stage Type 2 Diabetes
por: Sangalli, Elena, et al.
Publicado: (2020)

Licensing of Generic Medicines: Are There Any Challenges Left? A Pharmaceutical Regulatory Perspective
por: Borg, John Joseph, et al.
Publicado: (2014)

Mesenchymal stem cell treatment for COVID-19
por: Xu, Ruonan, et al.
Publicado: (2022)

Mesenchymal Stem Cells in the Treatment of COVID-19
por: Guo, Bei-Cyuan, et al.
Publicado: (2023)

Is there any role of staging laparoscopy in pancreatic adenocarcinoma?
por: Soni, Theresa, et al.
Publicado: (2023)

Combating COVID-19 with mesenchymal stem cell therapy
por: Rajarshi, Keshav, et al.
Publicado: (2020)

Mesenchymal stem cell therapy for severe COVID-19
por: Shi, Lei, et al.
Publicado: (2021)

Neonates with Covid-19 infection: Is there any different treatment process?
por: Pakdel, Manizhe, et al.
Publicado: (2022)

Is there any clinical significance of compression of left common iliac vein?
por: Lee, Yoon Soon
Publicado: (2014)

Any data, any time, any where
por: Malik, Sudhir
Publicado: (2013)

Bone marrow pericyte dysfunction in individuals with type 2 diabetes
por: Mangialardi, Giuseppe, et al.
Publicado: (2019)

The Treatment of Pruritus Ani
Publicado: (1904)

Statins in COVID-19: Is there any foundation?()
por: Lima Martínez, Marcos M., et al.
Publicado: (2020)

Mesenchymal stem cells in the treatment of severe COVID-19
por: Kesari, Santosh, et al.
Publicado: (2021)

Challenges for Mesenchymal Stem Cell-Based Therapy for COVID-19
por: Li, Chenghai, et al.
Publicado: (2020)

Mesenchymal stem cells as a potential therapy for COVID-19
por: Liu, Shan, et al.
Publicado: (2020)

Mesenchymal Stem Cell Therapy for COVID-19: Present or Future
por: Golchin, Ali, et al.
Publicado: (2020)

Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
por: Häberle, Helene, et al.
Publicado: (2021)

Activation of Bone Marrow Adaptive Immunity in Type 2 Diabetes: Rescue by Co-stimulation Modulator Abatacept
por: Santopaolo, Marianna, et al.
Publicado: (2021)

Transfer of a human gene variant associated with exceptional longevity improves cardiac function in obese type 2 diabetic mice through induction of the SDF‐1/CXCR4 signalling pathway
por: Dang, Zexu, et al.
Publicado: (2020)

The longevity-associated BPIFB4 gene supports cardiac function and vascularization in ageing cardiomyopathy
por: Cattaneo, Monica, et al.
Publicado: (2023)

Peptide Receptor Radionuclide Therapy During the COVID-19 Pandemic: Are There Any Concerns?
por: Bodei, Lisa, et al.
Publicado: (2020)

Cardiovascular complications of COVID-19: evidence, misconceptions, and new opportunities
por: Madeddu, Paolo
Publicado: (2020)

Bibliometric and visual analysis of mesenchymal stem cells in the treatment of osteoporosis based on CiteSpace software
por: Wang, Runfang, et al.
Publicado: (2022)

Treatment of Prolapsus Ani in Children
Publicado: (1876)

Cannot write session to /tmp/vufind_sessions/sess_krcbv9g6kq9abj8888pmjr4a46